An obvious physiologic explanation is not apparent, but these AT changes were small, may not be clinically significant, and, except for BMI, did not reach statistical significance.
← all excerpts
Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.
1
—
—